Written question asked by Lord Morris of Manchester (Labour), in the House of Lords. It was answered by Earl Howe (Conservative) on Wednesday, 19 October 2011.
Drugs: Pyridostigmine Bromide
- Question
- To ask Her Majesty’s Government what legal advice they have taken in regard to their legal responsibility in having funded the use of pyridostigmine bromide prescribed to NHS patients and any illnesses this has caused.
- Answer
-
The Government have not taken legal advice on the prescribing of pyridostigmine bromide to National Health Service patients. Pyridostigmine bromide is licensed, in the community, for the treatment of myasthenia gravis, paralytic ileus and post-operative urinary retention, and, as for all licensed medicines, its safety in clinical use is monitored by the Medicines and Healthcare products Regulatory Agency (a process known as pharmacovigilance).
Secondary information
- Type
- Written question
- Reference
- 12378; 731 c70WA
- Session
- 2010-12
- Subjects
- Pyridostigmine bromide
- Link
- View this Written question on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2024-04-23 09:17:33 +0100
- URI
- http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1644525
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1644525
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1644525